Ilumya Subcutaneous Injection 100mg Syringe

Ilumya Subcutaneous Injection 100mg Syringe contains tildrakizumab (genetical recombination) and is manufactured by Sun Pharma. Ilumya is an interleukin-23 antagonist indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. This injectable drug, with YJ code 3999456G1025, is supplied as 100mg in 1mL per tube.